StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Petros Pharmaceuticals's total debt was $4.92M at Sep 30, 2024. For fiscal 2023 it was $6.86M, down 18.2% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$6.86M-18.2%
FY2022Dec 31, 2022$8.39M+16.9%
FY2020Dec 31, 2020$7.18M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024$4.92M-32.1%
Q2 FY2024Jun 30, 2024$5.70M-25.4%
Q1 FY2024Mar 31, 2024$6.46M-19.4%
Q4 FY2023Dec 31, 2023$6.86M-18.2%
Q3 FY2023Sep 30, 2023$7.25M-17.2%
Q2 FY2023Jun 30, 2023$7.63M-16.3%
Q1 FY2023Mar 31, 2023$8.01M-15.4%
Q4 FY2022Dec 31, 2022$8.39M+144.9%
Q3 FY2022Sep 30, 2022$8.76M+73.0%
Q2 FY2022Jun 30, 2022$9.12M+27.1%
Q1 FY2022Mar 31, 2022$9.48M–
Q2 FY2021Jun 30, 2021$3.43M–
Q1 FY2021Mar 31, 2021$5.06M–
Q4 FY2020Dec 31, 2020$7.18M–

More Petros Pharmaceuticals figures

See a number that looks wrong?